12 Billion dollar deal for Japanese Pharmaceutical Company

Japan's Takeda Pharmaceutical is in talks to buy privately-held Swiss rival Nycomed, in a deal that could be worth more than 1 trillion yen ($12 billion).
The scale of this buyout is incredibly large. Exact details are still not known but fund manager at Chibagin Asset Management, Hiroaki Osakabe, states that Takeda has carried out this kind of strategy for a long time.
Sources told Reuters Takeda had hired Deutsche Securities as an advisor. One source said that the deal was in its final stages. Another said that Takeda is talking with several megabanks about financing and that the banks were prepared to lend the money if an agreement was reached.